Uric acid as a potential cue to screen for iron overload

Journal of the American Board of Family Medicine

Volumn 24, Issue 4, 2011, Pages 415-421

  Mainous III, Arch G ^a   Knoll, Michele E ^a   Everett, Charles J ^a   Matheson, Eric M ^a   Hulihan, Mary M ^b   Grant, Althea M ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Iron overload; NHANES; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; FERRITIN; GLUTAMATE TRANSAMINASE; IRON; LIVER ENZYME; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ETHNICITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON OVERLOAD; KIDNEY FUNCTION; LIVER FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREDICTION; PROTEINURIA; SEX; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HUMANS; IRON OVERLOAD; KIDNEY FUNCTION TESTS; LIVER; LIVER FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROTEINURIA; RISK ASSESSMENT; UNITED STATES; URIC ACID;

EID: 79960192046     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2011.04.110015     Document Type: Article

References (31)

1. McLaren GD, McLaren CE, Adams PC, et al. Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol 2008;22:923-30.
2. Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008;358:221-30.
3. Centers for Disease Control and Prevention. Hemochromatosis: (Iron Storage Disease), Facts, NCBDDD 6/1/2011. http://www.cdc.gov/ncbddd/ hemochromatosis/facts.html.
4. Waalen J, Felitti VJ, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008;111:3373-6.
5. US Preventive Services Task Force. Screening for hemochromatosis: recommendation statement. Ann Intern Med 2006;145:204-8.
6. Phatak PD, Bonkovsky HL, Kowdley KV. Hereditary hemochromatosis: time for targeted screening. Ann Intern Med 2008;149:270-2.
7. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33:S11-S61.
8. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001;134:509-17. (Pubitemid 32225955)
9. Merriman TR, Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint Bone Spine 2011;78:35-40.
10. Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36:2342-5.
11. Weaver AL. Epidemiology of gout. Clev Clin J Med 2008;75(Suppl 5):S9-S12.
12. Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One. 2010;5(7):e11578.
13. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-90.
14. Ghio AJ, Ford ES, Kennedy TP, Hoidal JR. The association between serum ferritin and uric acid in humans. Free Radic Res 2005;39:337-42. (Pubitemid 40439396)
15. National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov/nchs/nhanes.htm. Accessed 4 August 2010.
16. Addison G, Beamish M, Hales C, et al. An immunoradiometric assay for ferritin in the serum of normal patients and patients with iron deficiency and iron overload. J Clin Path 1972;25:326.
17. Miles L. Measurement of serum ferritin by a 2-site immunoradiometric assay. In: Abraham G, ed. Handbook of radioimmunoassay. New York: Marcel Dekker, Inc., 1977;131-177.
18. Centers for Disease Control and Prevention. Hemochromatosis (iron storage disease): training & education - treatment & management. Monitoring treatment. Available at: http://www.cdc.gov/ncbddd/hemochromatosis/training/ treatment/monitoring-treatment.html. Accessed 30 December 2010.
19. Iron Disorders Institute. Iron tests. Available at: http://www. irondisorders.org/iron-tests/. Accessed 30 December 2010.
20. Schlesinger N. Diagnosis of gout: clinical, laboratory, and radiologic findings. Am J Manag Care 2005;11:S443-50.
21. Pascual-Figal DA, Hurtado-Martínez JA, Redondo B, Antolinos MJ, Ruiperez JA, Valdes M. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007;9(5):518-24. (Pubitemid 46561480)
22. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;138:627-33.
23. Afzali A, Weiss NS, Boyko EJ, Ioannou GN. Association between serum uric acid level and chronic liver disease in the United States. Hepatology 2010;52:578-89.
24. National Center for Health Statistics, Centers for Disease Control and Prevention. NHANES 1999-2000 data documentation. Revised August 2006. Laboratory 18-biochemistry profile. Available at: http://www.cdc.gov/nchs/data/nhanes/ nhanes-99-00/lab18-doc.pdf. Accessed 18 May 2011.
25. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-97. (Pubitemid 35386908)
26. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988;255:F539-44.
27. Alfrey AC, Froment DH, Hammond WS. Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis. Kidney Int 1989;36:753-9. (Pubitemid 19283272)
28. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981;78:6858-62. (Pubitemid 12216861)
29. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41(6):1183-90.
30. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000;148(1):131-9.
31. Sudman S, Warnecke R, Johnson T, O'Rourke D, Davis AM. Cognitive aspects of reporting cancer prevention examination and texts. Vital Health Stat 6. 1994;7:1-171.